Dow gains 400 points as S&P 500, Russell 2000 hit records

This post was originally published on this site

U.S. stocks gained momentum in the final hour of trading posting a suite of fresh records as investors focused on vaccine optimism.

Continue Reading Below

Ticker Security Last Change Change %
I:DJI DOW JONES AVERAGES 29479.81 +399.64 +1.37%
SP500 S&P 500 3585.15 +48.14 +1.36%
I:COMP NASDAQ COMPOSITE INDEX 11829.285546 +119.70 +1.02%

The Dow Jones Industrial Average rose 400 points or 1.37%, while the S&P 500 gained 1.36% closing at a fresh record. The Nasdaq Composite ticked up by 1% recovering late in the session.

MIGHTY U.S. SMALL CAPS HIT RECORDS

The Russell 2000, a benchmark of domestic-focused companies, hit a record on Friday passing levels not seen since August 2018.

For the week, the Dow tacked on about 4%, the S&P over 2% while Nasdaq slipped 0.5%.

GLOBAL STOCK FUNDS SEE RECORD INFLOWS ON PFIZER’S COVID-19 VACCINE

Global stock funds attracted record inflows this week topping $44 billion.

Ticker Security Last Change Change %
DIS WALT DISNEY COMPANY 138.36 +2.84 +2.10%

Dow member Disney fueling some of the gains after reporting better-than-expected quarterly results, even with the negative impact of the pandemic.

DISNEY+ SILVER LINING IN PANDEMIC PLAGUED QUARTER

Other stocks getting an earnings boost; Cisco which benefited from a jump in teleconferencing tied to the rise of working from home. The stock is on pace for the best session since February 2018.

Aso, DraftKings jumped after boosting its outlook, as sporting events restart and more consumers wager bets.

Ticker Security Last Change Change %
CSCO CISCO SYSTEMS INC. 41.40 +2.73 +7.06%
DKNG DRAFTKINGS 42.84 +1.59 +3.85%

Vaccine companies also in focus including Pfizer, BioNTech, Eli Lilly along with Regeneron and Moderna.

Health and Human Services Secretary Alex Azar, speaking on FOX Business, said the distribution network is ready to go once a vaccine arrives.

“Pfizer will be doing its own direct distribution to pharmacies that we ask them to send to based on the instructions of our nation’s governors under their distribution plan. So the vaccine will arrive at these pharmacies, white-glove service and the pharmacies will then execute distribution plans to the targeted populations that the governors have selected” he explained.

Ticker Security Last Change Change %
PFE PFIZER INC. 38.62 +1.07 +2.85%
BNTX BIONTECH SE 106.00 +4.37 +4.30%
LLY ELI LILLY & COMPANY 142.38 +1.35 +0.96%
REGN REGENERON PHARMACEUTICALS INC. 566.43 +9.65 +1.73%
MRNA MODERNA INC. 89.39 +1.58 +1.80%

Pharmacy chains and grocers will make up a vast distribution network once a vaccine is approved. CVS, Rite Air, Walgreens, Walmart and Kroger taking the lead.

Ticker Security Last Change Change %
CVS CVS HEALTH CORPORATION 71.00 +1.61 +2.32%
RAD RITE AID 11.85 +0.18 +1.54%
WBA WALGREENS BOOTS ALLIANCE INC. 42.71 +1.94 +4.76%
WMT WALMART INC. 150.54 +2.31 +1.56%
KR KROGER 32.14 +0.11 +0.34%

SPACE STOCKS

Investors are closely watching Elon Musk’s SpaceX launch set for Saturday putting renewed attention on the space stocks.

Ticker Security Last Change Change %
SPCE VIRGIN GALACTIC HOLDINGS INC. 22.27 +0.65 +3.01%
UFO PROCURE ETF TRUST II PROCURE SPACE ETF 23.70 +0.69 +3.02%

OIL SLIPS LOWER

West Texas Intermediate crude lost over 8% for the week settling at the $40 per barrel level as investors debate how much demand may rebound when a vaccine hits the market.

ECONOMIC DATA

As for economic data, the Producer Price Index rose 0.5% year-over-year slightly higher than estimates tracked by Refinitiv. Excluding the volatile food and energy component, prices rose 1.1% year-over-year.

In other reports, the University of Michigan’s preliminary index of consumer sentiment for November came in at 77 slightly below the expected 82. This represents a real-time sentiment picture vs. other lagging indicators.

“The outcome of the presidential election as well as the resurgence in covid infections and deaths were responsible for the early November decline,” wrote Surveys of Consumers chief economist, Richard Curtin.

CLICK HERE TO READ MORE ON FOX BUSINESS